𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radiotherapy as an adjunct in the management of merkel cell carcinoma

✍ Scribed by Michael E. Marks; Robert Y. Kim; Merle M. Salter


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
586 KB
Volume
65
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Merkel cell carcinoma of the head and ne
✍ Jonathan R. Clark; Michael J. Veness; Ralph Gilbert; Christopher J. O'Brien; Pat πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 403 KB πŸ‘ 2 views

## Abstract ## Background. Controversy exists regarding the optimal management of patients with Merkel cell carcinoma. The primary aim of this study was to determine whether combined treatment with surgery and radiotherapy improves outcome in a multi‐institutional cohort of patients with Merkel ce

Adjuvant locoregional radiotherapy as be
✍ Michael J. Veness; Gary J. Morgan; Val Gebski πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 180 KB πŸ‘ 2 views

Background. Australians have the highest rate of skin cancer in the world. Merkel cell carcinoma (MCC) is the most aggressive skin cancer reported, with a high propensity for relapse. The purpose of this study was to report the patterns of recurrence after initial treatment, the outcomes, and any pr

Radiotherapy for merkel cell carcinoma o
✍ Dr. Mohan Suntharalingam; Dr. Marc S. Rudoltz; Dr. William M. Mendenhall; Dr. Ja πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 462 KB πŸ‘ 2 views

## Abstract __Background.__ Merkel cell carcinoma is a relatively rare neuroendocrine carcinoma of the skin. It arises in the head and neck region in approximately 50% of cases. Its aggressive behavior predisposes patients to local‐regional recurrence and distant metastases after surgical excision

Adjunctive radiotherapy in the treatment
✍ Weston Waxweiler; Justin R. Sigmon; Daniel J. Sheehan πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 54 KB

Perineural invasion is a feature associated with significantly poorer outcomes when present in cutaneous squamous cell carcinoma (CSCC). The incidence of this subset of CSCC continues to rise in the US, as does the confusion surrounding exactly how it should be managed. While management typically in